The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Patient Home Monitoring Corp

Venture: PHM
Delayed quote

$1.57

Today's change+0.18 +12.95%
Updated April 28 2:39 PM EDT. Delayed by at least 15 minutes.
 

Patient Home Monitoring Corp

Venture: PHM
Delayed quote

$1.57

Today's change+0.18 +12.95%
Updated April 28 2:39 PM EDT. Delayed by at least 15 minutes.

Patient Home Monitoring Corp crosses above 50-day moving average

Patient Home Monitoring Corp is up sharply today, rallying $0.18 or 12.95% to $1.57 and crossing above its 50-day moving average. Shares have lost 17.37% over the last five days, but have gained 80.46% over the last year to date. This security has outperformed the S&P TSX by 592.25% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward29.57×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.03
Updated April 28 2:39 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-15.18%

Patient Home Monitoring Corp has a net profit margin of -15.18%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.07%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue101064
Total other revenue--------
Total revenue101064
Gross profit7732
Total cost of revenue3321
Total operating expense91253
Selling / general / administrative6732
Research & development--------
Depreciation / amortization--1----
Interest expense (income), net operating----00
Unusual expense (income)0200
Other operating expenses, total--------
Operating income1-310
Interest income (expense), net non-operating00----
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-512
Income after tax-3-412
Income tax, total0000
Net income-3-412
Total adjustments to net income--------
Net income before extra. items-3-412
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-412
Inc. avail. to common incl. extra. items-3-412
Diluted net income-3-412
Dilution adjustment0000
Diluted weighted average shares175140135129
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.030.010.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.020.010.01